Assessment of Minimal Residual Disease (MRD) After Antineoplastic Treatment in Patients With AL Amyloidosis
Clinical trial NCT02716103 · COMPLETED
Trial details
- NCT number
- NCT02716103
- Sponsor
- Boston Medical Center
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-11-21
- Primary completion
- 2020-09-04
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.